Abacavir-Lamivudine

Generic name

Abacavir Sulfate/Lamivudine

Covered by Medicare

Yes

Get a Medicare Quote

Average Annual Cost per Beneficiary

$2,395.41

Average cost per year*

Average Annual Cost per Dose

$8.40

-21.96%

Average cost per beneficiary*

Manufacturer(s)

  • Cipla USA, Inc.
  • Lupin Pharmaceu
  • Aurobindo Pharm
  • Teva USA
  • Burel Pharmaceu

What is Abacavir-Lamivudine

This product contains 2 drugs: abacavir and lamivudine. It is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine both belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Abacavir/lamivudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page: https://data.cms.gov/

Common Questions About Abacavir-Lamivudine

Yes, Abacavir-Lamivudine is covered by Medicare.

In 2021, the average cost per dose of Abacavir-Lamivudine was $8.40.

The average dose of Abacavir-Lamivudine received per year is 1,507,397 units

4,032 Medicare beneficiaries received Abacavir-Lamivudine in 2021, which was a -0.15% from 2020

There were 30,251 claims made by Medicare beneficiaries, which is a -0.19% from 2020

The average spending amount per claim in 2021 was $319.27

The average Medicare spending per beneficiary amount for Abacavir-Lamivudine was $2,395.41

The most expensive manufacturer of Abacavir-Lamivudine is Lupin Pharmaceu

Cipla USA, Inc. is the least expensive manufacturer with an Average Spending Per Dosage Unit of $7.92

Cipla USA, Inc. received $3,574,313.32

The total amount spent on Abacavir-Lamivudine by Medicare is $9,658,297.01

© 2021-2023 HealthInsurance.com, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS

Healthinsurance.com is a commercial site designed for the solicitation of insurance from selected health insurance carriers and HealthInsurance.com, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider. HealthInsurance.com, LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.

We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.

Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.

If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.

The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.

Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.

Multi-Plan_HIC_Web_M